FHU CARE aims at bringing together clinicians and scientists involved in Autoimmune Diseases, Inflammatory Diseases and Cancer to favor the emergence of new paradigms :

Pathophysiology of Cancer and of Autoimmune Diseases (AID) / Inflammatory Diseases (ID) may share common or opposite mechanisms.
Treatment of Autoimmunity and treatment of Cancer are inter-related.

Presentation of FHU CARE by Professor Xavier Mariette

FHU CARE WORK PACKAGES

Our community is very rich in experts involved in auto-immunity/inflammation and cancer focused on the following research actions :

All Work Packages All our Experts

Common pathways involved in Autoimmune Diseases, Cancer and Inflammatory Diseases

Adaptive and innate Immunity. The balance between pro vs anti-Inflammatory Immune cells (macrophages, T cells, dendritic cells) is opposed in C vs AID/ID.

Auto-Immunity and Inflammation are risk factors of Cancer

Risk of Cancer in Autoimmune Diseases and Inflammatory Diseases. Risks, implications and evolution, drugs and new perspectives in Cancer Immune surveillance.

Immune-Related Adverse Events (irAEs), in the immunotherapy of Cancer

Management of adverse events, modulation of Autoimmunity, modulating microbiome treatment to cure Cancer.

Teaching the relation between Auto-Immunity and Cancer

Specific training on Autoimmune Diseases, Cancer and Inflammatory Diseases, will be implemented in the University Diplomas.

CLINICAL RESEARCH:
Observational studies
Interventional studies
Clinical trials

Observational studies: They improve the knowledge of the disease and its evolution over time. They are carried out within the framework of the follow-up of the patients in the reference centers.

Interventional studies or clinical trials: They provide scientific evidence of the efficacy and safety of a new drug, a new care device or a new management in the context of an illness. This is the necessary step for a new molecule to become a drug or a new medical device to be marketed.

E-TRAINING BY FHU CARE

Online Courses :
Management of Immuno-Related Complications Cancer Immunotherapy

Learn more about immunotherapy in oncology with 3 modules:

Identify the main molecules and their mechanisms of action
Learn more about the actual and forecoming indications
Identify and manage Immune related adverse events

For more information

Presentation of FHU CARE courses by Professor Olivier Lambotte

Addressing poorly-understood tumour-host interactions to enhance immune system-centred treatment and care interventions in childhood, adolescent, adult and elderly cancer patients.

Common pathways

Auto-immunity and inflammation

Immune-Related Adverse Events

Teaching the relation